Peptides mediating interaction networks: new leads at last

Current Opinion in Biotechnology

Volumn 17, Issue 5, 2006, Pages 465-471

  Neduva, Victor ^a   Russell, Robert B ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERACTION NETWORKS; PROTEIN BINDING; PROTEIN INTERACTIONS;

BIOTECHNOLOGY; DATA PROCESSING; LARGE SCALE SYSTEMS; MOLECULES; TARGETS;

POLYPEPTIDES;

PEPTIDE; TOXIN;

AMINO ACID SEQUENCE; BINDING AFFINITY; BINDING SITE; BIOCHEMISTRY; BIOINFORMATICS; CARCINOGENICITY; CELL CYCLE; COMPARATIVE STUDY; HUMAN; MATHEMATICAL COMPUTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; SEQUENCE ANALYSIS;

BINDING SITES; MODELS, BIOLOGICAL; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33748953868     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2006.08.002     Document Type: Review

References (40)

1. Rual J.F., Venkatesan K., Hao T., Hirozane-Kishikawa T., Dricot A., Li N., Berriz G.F., Gibbons F.D., Dreze M., Ayivi-Guedehoussou N., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437 (2005) 1173-1178. One of the first publications of genome-scale yeast two-hybrid studies involving human proteins. This study identified some 2800 interactions involving 1549 proteins. The data reveals more than 300 new connections to over 100 disease-associated proteins.
2. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 122 (2005) 957-968. One of the first publications on genome-scale yeast two-hybrid studies involving human proteins. This study identified some 3186 interactions involving 1705 proteins. The interaction map links 195 disease-related proteins to previously unidentified partners, allows the description of 342 uncharacterized human proteins via their interactions, and suggests new roles for hundreds of known proteins.
3. Gavin A.C., Aloy P., Grandi P., Krause R., Boesche M., Marzioch M., Rau C., Jensen L.J., Bastuck S., Dumpelfeld B., et al. Proteome survey reveals modularity of the yeast cell machinery. Nature 440 (2006) 631-636
4. Krogan N.J., Cagney G., Yu H., Zhong G., Guo X., Ignatchenko A., Li J., Pu S., Datta N., Tikuisis A.P., et al. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440 (2006) 637-643
5. Aloy P., and Russell R.B. Interrogating protein interaction networks through structural biology. Proc Natl Acad Sci USA 99 (2002) 5896-5901
6. Lu L., Arakaki A.K., Lu H., and Skolnick J. Multimeric threading-based prediction of protein-protein interactions on a genomic scale: application to the Saccharomyces cerevisiae proteome. Genome Res 13 (2003) 1146-1154
7. Fischer P.M., and Lane D.P. Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets?. Trends Pharmacol Sci 25 (2004) 343-346
8. Gadek T.R., Burdick D.J., McDowell R.S., Stanley M.S., Marsters Jr. J.C., Paris K.J., Oare D.A., Reynolds M.E., Ladner C., Zioncheck K.A., et al. Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science 295 (2002) 1086-1089
9. He M.M., Smith A.S., Oslob J.D., Flanagan W.M., Braisted A.C., Whitty A., Cancilla M.T., Wang J., Lugovskoy A.A., Yoburn J.C., et al. Small-molecule inhibition of TNF-α. Science 310 (2005) 1022-1025. A rare example of a small-molecule capable of disrupting a large interaction surface, specifically those interactions involved in the formation of the tumor necrosis factor (TNF) trimer. The compound causes trimer dissociation and thus inhibition of the TNFα pathway.
10. Davis B.D., and Tai P.C. The mechanism of protein secretion across membranes. Nature 283 (1980) 433-438
11. Semenza J.C., Hardwick K.G., Dean N., and Pelham H.R. ERD2, a yeast gene required for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway. Cell 61 (1990) 1349-1357
12. Puntervoll P., Linding R., Gemund C., Chabanis-Davidson S., Mattingsdal M., Cameron S., Martin D.M., Ausiello G., Brannetti B., Costantini A., et al. ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res 31 (2003) 3625-3630
13. Obenauer J.C., Cantley L.C., and Yaffe M.B. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31 (2003) 3635-3641
14. Sigrist C.J., Cerutti L., Hulo N., Gattiker A., Falquet L., Pagni M., Bairoch A., and Bucher P. PROSITE: a documented database using patterns and profiles as motif descriptors. Brief Bioinform 3 (2002) 265-274
15. Mishra G.R., Suresh M., Kumaran K., Kannabiran N., Suresh S., Bala P., Shivakumar K., Anuradha N., Reddy R., Raghavan T.M., et al. Human protein reference database -2006 update. Nucleic Acids Res 34 (2006) D411-D414
16. Landgraf C., Panni S., Montecchi-Palazzi L., Castagnoli L., Schneider-Mergener J., Volkmer-Engert R., and Cesareni G. Protein interaction networks by proteome peptide scanning. PLoS Biol 2 (2004) E14
17. Ptacek J., Devgan G., Michaud G., Zhu H., Zhu X., Fasolo J., Guo H., Jona G., Breitkreutz A., Sopko R., et al. Global analysis of protein phosphorylation in yeast. Nature 438 (2005) 679-684. Reports a phosphorylation map for the yeast proteome derived using protein chips. The binding activity of 87 yeast kinases was mapped and more than 4000 phosphorylation events were detected, including many thousands that were previously unknown. A clear demonstration that chip technology can identify novel linear motif binding sites.
18. Jones R.B., Gordus A., Krall J.A., and MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439 (2006) 168-174. Describes how protein arrays can be used to map peptide-mediated interactions of a particular class (phosphorylated tyrosines). A protein array of all human phosphotyrosine-binding modules was probed with 61 peptides representing physiological tyrosine phosphorylation sites on the four ErbB receptors, leading to a comprehensive view of potential phosphotyrosine-mediated interactions for this protein family. At higher concentrations the oncogenic ErbB1 and ErbB2 become more promiscuous than ErbB3, possibly explaining part of their role in pathogenesis.
19. Bateman A., Birney E., Cerruti L., Durbin R., Etwiller L., Eddy S.R., Griffiths-Jones S., Howe K.L., Marshall M., and Sonnhammer E.L. The Pfam protein families database. Nucleic Acids Res 30 (2002) 276-280
20. Neduva V., Linding R., Su-Angrand I., Stark A., de Masi F., Gibson T.J., Lewis J., Serrano L., and Russell R.B. Systematic discovery of new recognition peptides mediating protein interaction networks. PLoS Biol 3 (2005) e405. The first systematic attempt to uncover new interactions mediated by linear motifs. The authors looked for over-represented sequence patterns within all sets of proteins sharing an interaction partner from genome-scale interaction data from yeast, fly, nematode and human. They re-discovered many known motifs (SH3/PxxP etc.) and predicted many others that were completely new. For two new motifs they demonstrated that peptides containing the motif bound directly to the predicted partner.
21. Neduva V., and Russell R.B. DILIMOT: Discovery of linear motifs in proteins. Nucleic Acids Res 34 Web Server issue (2006) W350-W355. This paper introduces DILIMOT: a method for finding potential linear motifs mediating an interaction or some other common function, such as cellular location, shared by a set of sequences.
22. Davey N., Shields D., and Edwards R. SLiMDisc: Short, Linear Motif discovery, correcting for common evolutionary descent. Nucleic Acids Res 34 (2006) 3546-3554. This paper introduces SLiMDisc: a method for finding potential linear motifs mediating an interaction or some other common function, such as cellular location, shared by a set of sequences.
23. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., and Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 (1998) 927-937
24. Remaut H., and Waksman G. Protein-protein interaction through β-strand addition. Trends Biochem Sci 31 (2006) 436-444
25. Pawson T., and Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 300 (2003) 445-452
26. Peterson F.C., Penkert R.R., Volkman B.F., and Prehoda K.E. Cdc42 regulates the Par-6 PDZ domain through an allosteric CRIB-PDZ transition. Mol Cell 13 (2004) 665-676
27. Zarrinpar A., Bhattacharyya R.P., and Lim W.A. The structure and function of proline recognition domains. Sci STKE 2003 (2003) RE8
28. Li Y., Huang Q., Zhang S., Liu S., Chi C., and Tang Y. Studies on an artificial trypsin inhibitor peptide derived from the mung bean trypsin inhibitor: chemical synthesis, refolding, and crystallographic analysis of its complex with trypsin. J Biochem (Tokyo) 116 (1994) 18-25
29. Rittinger K., Budman J., Xu J., Volinia S., Cantley L.C., Smerdon S.J., Gamblin S.J., and Yaffe M.B. Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell 4 (1999) 153-166
30. Kussie P.H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., and Pavletich N.P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274 (1996) 948-953
31. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848. Among the first examples of a synthetic small-molecule inhibitor disrupting a peptide- (and in this case a linear motif) mediated interaction: the interaction between MDM2 and p53. The study demonstrates the possibility of using traditional drug discovery techniques (i.e. chemical library screens, competitions assays, etc.) to develop compounds that act on medically important protein interactions directly.
32. Bonacci T.M., Mathews J.L., Yuan C., Lehmann D.M., Malik S., Wu D., Font J.L., Bidlack J.M., and Smrcka A.V. Differential targeting of Gβγ-subunit signaling with small molecules. Science 312 (2006) 443-446. An intriguing example of subtle functional regulation through selective disruption of different peptide-mediated interactions, specifically between G-protein βγ subunits and various binding partners. Small-molecules could be found that selectively disrupt protein interactions with the canonical G-protein βγ subunit partners and differentially modulate functions downstream of G-protein-coupled receptors.
33. Wurtele M., Jelich-Ottmann C., Wittinghofer A., and Oecking C. Structural view of a fungal toxin acting on a 14-3-3 regulatory complex. EMBO J 22 (2003) 987-994. A structural explanation of the synergistic effect resulting from the simultaneous binding of a small-molecule toxin and a linear motif containing peptide. The structure of a plant 14-3-3 protein bound to both a toxin and one of its natural ligands showed that they occupied adjacent parts of the same pocket, explaining how the interaction was made 90-fold stronger in the presence of the toxin.
34. Sehnke P.C., DeLille J.M., and Ferl R.J. Consummating signal transduction: the role of 14-3-3 proteins in the completion of signal-induced transitions in protein activity. Plant Cell 14 Suppl (2002) S339-S354
35. Terrak M., Kerff F., Langsetmo K., Tao T., and Dominguez R. Structural basis of protein phosphatase 1 regulation. Nature 429 (2004) 780-784
36. Maynes J.T., Luu H.A., Cherney M.M., Andersen R.J., Williams D., Holmes C.F., and James M.N. Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins. J Mol Biol 356 (2006) 111-120
37. Russell R.B., and Eggleston D.S. New roles for structure in biology and drug discovery. Nat Struct Biol 7 Suppl (2000) 928-930
38. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The Protein Data Bank. Nucleic Acids Res 28 (2000) 235-242
39. Humphrey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J Mol Graph 14 (1996) 33-38 27-38
40. Russell R.B., and Barton G.J. Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels. Proteins 14 (1992) 309-323